Machine learning for predicting psychotic relapse at 2 years in schizophrenia in the national FACE-SZ cohort
- PMID: 30552914
- DOI: 10.1016/j.pnpbp.2018.12.005
Machine learning for predicting psychotic relapse at 2 years in schizophrenia in the national FACE-SZ cohort
Abstract
Background: Predicting psychotic relapse is one of the major challenges in the daily care of schizophrenia.
Objectives: To determine the predictors of psychotic relapse and follow-up withdrawal in a non-selected national sample of stabilized community-dwelling SZ subjects with a machine learning approach.
Methods: Participants were consecutively included in the network of the FondaMental Expert Centers for Schizophrenia and received a thorough clinical and cognitive assessment, including recording of current treatment. Relapse was defined by at least one acute psychotic episode of at least 7 days, reported by the patient, her/his relatives or by the treating psychiatrist, within the 2-year follow-up. A classification and regression tree (CART) was used to construct a predictive decision tree of relapse and follow-up withdrawal.
Results: Overall, 549 patients were evaluated in the expert centers at baseline and 315 (57.4%) (mean age = 32.6 years, 24% female gender) were followed-up at 2 years. On the 315 patients who received a visit at 2 years, 125(39.7%) patients had experienced psychotic relapse at least once within the 2 years of follow-up. High anger (Buss&Perry subscore), high physical aggressiveness (Buss&Perry scale subscore), high lifetime number of hospitalization in psychiatry, low education level, and high positive symptomatology at baseline (PANSS positive subscore) were found to be the best predictors of relapse at 2 years, with a percentage of correct prediction of 63.8%, sensitivity 71.0% and specificity 44.8%. High PANSS excited score, illness duration <2 years, low Buss&Perry hostility score, high CTQ score, low premorbid IQ and low medication adherence (BARS) score were found to be the best predictors of follow-up withdrawal with a percentage of correct prediction of 52.4%, sensitivity 62%, specificity 38.7%.
Conclusion: Machine learning can help constructing predictive score. In the present sample, aggressiveness appears to be a good early warning sign of psychotic relapse and follow-up withdrawal and should be systematically assessed in SZ subjects. The other above-mentioned clinical variables may help clinicians to improve the prediction of psychotic relapse at 2 years.
Keywords: Aggressiveness; Machine learning; Prediction; Relapse; Schizophrenia.
Copyright © 2018 Elsevier Inc. All rights reserved.
Similar articles
-
Medication and aggressiveness in real-world schizophrenia. Results from the FACE-SZ dataset.Psychopharmacology (Berl). 2016 Feb;233(4):571-8. doi: 10.1007/s00213-015-4167-8. Epub 2015 Dec 3. Psychopharmacology (Berl). 2016. PMID: 26630993
-
Recommendations of the schizophrenia expert center network for the screening prevention and treatment of sleep disorders based on the results from the real-world schizophrenia FACE-SZ national cohort.Prog Neuropsychopharmacol Biol Psychiatry. 2021 Aug 30;110:110275. doi: 10.1016/j.pnpbp.2021.110275. Epub 2021 Feb 11. Prog Neuropsychopharmacol Biol Psychiatry. 2021. PMID: 33582207
-
Confirmations, advances and recommendations for the daily care of schizophrenia based on the French national FACE-SZ cohort.Prog Neuropsychopharmacol Biol Psychiatry. 2020 Jul 13;101:109927. doi: 10.1016/j.pnpbp.2020.109927. Epub 2020 Mar 12. Prog Neuropsychopharmacol Biol Psychiatry. 2020. PMID: 32173456 Review.
-
Chronic low-grade peripheral inflammation is associated with ultra resistant schizophrenia. Results from the FACE-SZ cohort.Eur Arch Psychiatry Clin Neurosci. 2019 Dec;269(8):985-992. doi: 10.1007/s00406-018-0908-0. Epub 2018 May 28. Eur Arch Psychiatry Clin Neurosci. 2019. PMID: 29808267
-
[Duration of untreated psychosis: A state-of-the-art review and critical analysis].Encephale. 2016 Aug;42(4):361-6. doi: 10.1016/j.encep.2015.09.007. Epub 2016 May 6. Encephale. 2016. PMID: 27161262 Review. French.
Cited by
-
Biomarker discovery using machine learning in the psychosis spectrum.Biomark Neuropsychiatry. 2024 Dec;11:100107. doi: 10.1016/j.bionps.2024.100107. Epub 2024 Aug 26. Biomark Neuropsychiatry. 2024. PMID: 39687745 Free PMC article.
-
Psychotic relapse in people with schizophrenia within 12 months of discharge from acute inpatient care: protocol for development and validation of a prediction model based on a retrospective cohort study in three psychiatric hospitals in Japan.Diagn Progn Res. 2022 Nov 3;6(1):20. doi: 10.1186/s41512-022-00134-w. Diagn Progn Res. 2022. PMID: 36324165 Free PMC article.
-
Prediction of quality of life in schizophrenia using machine learning models on data from Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial.Schizophrenia (Heidelb). 2022 Mar 21;8(1):29. doi: 10.1038/s41537-022-00236-w. Schizophrenia (Heidelb). 2022. PMID: 35314708 Free PMC article.
-
Accuracy of machine learning methods in predicting prognosis of patients with psychotic spectrum disorders: a systematic review.BMJ Open. 2025 Feb 25;15(2):e084463. doi: 10.1136/bmjopen-2024-084463. BMJ Open. 2025. PMID: 40000074 Free PMC article.
-
Implementing Precision Psychiatry: A Systematic Review of Individualized Prediction Models for Clinical Practice.Schizophr Bull. 2021 Mar 16;47(2):284-297. doi: 10.1093/schbul/sbaa120. Schizophr Bull. 2021. PMID: 32914178 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical